INTERPHARM HOLDINGS INC

As of December 31, 2007, INTERPHARM HOLDINGS INC carries a market capitalization of 28.70M, placing it among publicly traded companies globally. Its enterprise value stands at 67.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2007, INTERPHARM HOLDINGS INC has 66.74M shares outstanding.

These figures are as of December 31, 2007. The price-to-sales ratio is 0.41, and the price-to-book ratio stands at -5.37.

These figures are as of December 31, 2007. The EV/Sales ratio of 0.97 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 67.18M versus a market cap of 28.70M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2007, INTERPHARM HOLDINGS INC maintains a current ratio of 0.62, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2007. Return on assets (ROA) is negative at -44.00, reflecting losses generated across the asset base. The company generates approximately 110,296.41 in revenue per employee across its workforce of 627.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.19 indicates how many times INTERPHARM HOLDINGS INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended December 31, 2007, INTERPHARM HOLDINGS INC recorded 7.09M in income tax expense. The company reported a pretax loss of -22.27M and -29.36M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Over the twelve months ended December 31, 2007, INTERPHARM HOLDINGS INC generated 69.21M in revenue and converted that into -29.36M in net income, yielding earnings per share of -0.44. EBITDA reached -16.36M, while operating income came in at -19.71M.

As of December 31, 2007, INTERPHARM HOLDINGS INC holds 41,000.00 in cash and equivalents against 38.47M in total debt, resulting in a net debt position of 38.43M. Total book value stands at -5.34M, with working capital of -16.63M providing operational flexibility.

INTERPHARM HOLDINGS INC produced -21.74M in operating cash flow over the twelve months ended December 31, 2007. After subtracting -7.86M in capital expenditures, free cash flow totaled -29.61M - equivalent to -0.45 per share.

Over the twelve months ended December 31, 2007, INTERPHARM HOLDINGS INC posted a gross margin of 17.34, reflecting its pricing power and cost economics. The operating margin of -28.49 and net profit margin of -42.42 provide insight into operational efficiency.

Over the twelve months ended December 31, 2007, INTERPHARM HOLDINGS INC paid dividends of - - per share. The dividend payout ratio of 12.47 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -104.27: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -80.02, meaning INTERPHARM HOLDINGS INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

INTERPHARM HOLDINGS INC's most recent stock split took place on November 19, 1997 with a 5:1 split ratio.

As of December 31, 2007, INTERPHARM HOLDINGS INC has an Altman Z-Score of -0.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.